Breast Cancer;Cancer Research;Breast Cancer Recurrence;Combination Therapy

Adding ribociclib to hormone therapy reduces the risk of breast cancer recurrence

[ad_1] BYLINE: Denise Heady Newswise — A new treatment approach that combines a targeted therapy drug with hormone therapy significantly…